Imagion Biosystems Limited (ASX: IBX) (the Company), had former GE Healthcare executive and Non-Executive Director, Mike Harsh, speak to Scott Power on the Under the Microscope Podcast. In the first part of the interview, Mike talked about what attracted him to Imagion Biosystems, and why MagSense is set to significantly change medical imaging and cancer detection. Speaking in part two of the Under The Microscope podcast, Mike also shares his thoughts on the future of the medical imaging industry.
To hear the first part of the interview, please click through here. And the hear part two of the interview, please click through here.
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance